Malgorzata Baranska performs integrative Internal medicine and Oncology research in his work. He conducts interdisciplinary study in the fields of Oncology and Cancer research through his research. His Cancer research study frequently draws parallels with other fields, such as Nilotinib. In his works, Malgorzata Baranska performs multidisciplinary study on Nilotinib and Tyrosine-kinase inhibitor. While working in this field, he studies both Tyrosine-kinase inhibitor and Tyrosine kinase. He applies his multidisciplinary studies on Tyrosine kinase and Imatinib in his research. He integrates Imatinib and Dasatinib in his studies. His Myeloid leukemia research extends to Dasatinib, which is thematically connected. His work on Myeloid leukemia is being expanded to include thematically relevant topics such as Imatinib mesylate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: